Katja Wosikowski

Nonclinical Drug Development, Translational Medicine

CONELIS expert Katja Wosikowski

Wosikowski Consulting

Munich

German, English, Dutch

Services offered worldwide

Contact Me

Send me an Turn on Javascript!

Offers

Strategic Guidance

  • Expert advice on nonclinical development strategies for all therapeutic modalities.
  • Recommendations on prioritizing critical studies now versus those suitable for later stages.

Tailored Program Design and Execution

  • Development of customized pharmacology, DMPK, and toxicology programs to align with the sponsor’s objectives and regulatory requirements.
  • Translation to early clinical studies and hands-on oversight of PK, ADA and Biomarker analysis in clinical studies and interpretation of results. 

Scientific Alliance and Vendor Management

  • Support in selecting and managing CROs, ensuring alignment with project goals.
  • Proactive oversight of study conduct as a sponsor-designated study monitor, ensuring the quality and timeliness of deliverables
  • Comprehensive review, analysis, and interpretation of results and study reports.

Regulatory Documentation and Submissions

  • Preparation and compilation of non-clinical documentation for submissions such as CTA, IND, and IB.
  • Budgeting and timeline planning for CTA/IND-enabling non-clinical packages.
  • Engagement with regulatory authorities on non-clinical matters, including responses to questions

Program Evaluation and Due Diligence

  • Assessment of nonclinical programs for partnering opportunities, due diligence, and GAP analysis for preclinical projects, including in-licensed assets.

Operational Support

  • Hands-on support with day-to-day operational challenges
  • Reliable, knowledgeable, and adaptable support tailored to meet client needs

About Me

Nonclinical and Translational Drug Development expert and licensed pharmacist, binging over 25 years of experience in drug discovery and development of a wide range of innovative therapeutics. These include small molecule inhibitors, mRNA therapeutics, antisense molecules, fusion proteins, antibodies, antibody-drug conjugates, and herbal medicines. My expertise covers multiple therapeutic areas, including oncology, ophthalmology, neurology, thrombosis, and respiratory diseases. For most of my clients, I adopt a hands-on approach, actively engaging in day-to-day operational tasks to ensure seamless project execution.

Qualifications

Education

  • MSc in Pharmacy (Drs, Diploma)
  • Qualification as licensed Pharmacist (Approbation)
  • PhD: Pharmacology, Molecular Biology